# Rayca Precision

> Rayca Precision is an agentic AI drug-discovery company. Its self-improving engine designs, simulates, and triages therapeutic candidates across modalities for hard-to-drug targets, and preserves institutional memory across every program.

Rayca's engine composes its own discovery workflows, orchestrates multiple models and tools, scores candidates against binding physics with free-energy methods, and folds every result back into a queryable lineage. It works across modalities: small molecules, peptides, antibodies, nanobodies, degraders, PROTACs, and antibody-drug conjugates. The company is disease-agnostic and focuses on targets that resist conventional approaches.

## Pages

- [Home](https://rayca.ai/): The collective intelligence engine for drug discovery. Platform, science, and pipeline overview.
- [Newsroom](https://rayca.ai/news/): Press releases and announcements from Rayca Precision.

## Platform

- [The platform](https://rayca.ai/#platform): Agentic molecule design with institutional memory. Adaptive workflow synthesis, multi-model orchestration, physics-grade triage, and self-improvement by design.
- [The engine](https://rayca.ai/#engine): How discovery runs end to end as one system, step to step.
- [The discovery stack](https://rayca.ai/#stack): Target finding, molecular simulation, structure-aware design, free-energy scoring, data lineage, and self-auditing.
- [Self-improving workflow](https://rayca.ai/#agentic): A self-improving agentic operating layer that models proteins, designs modalities, scores against physics, curates lineage, and audits its own decisions.
- [Modalities](https://rayca.ai/#modalities): Built for hard targets, from small molecules to degraders, ADCs, and VHHs.
- [Rigor and trust](https://rayca.ai/#trust): End-to-end data and decision lineage. Every result traces to its inputs and people own every go and no-go.

## Contact

- [Partner with us](https://rayca.ai/): Co-development partnerships and fixed-scope discovery pilots. Use the Partner with us form on the site.

## Optional

- [Full site content](https://rayca.ai/llms-full.txt): The complete content of the site as a single document.
- [Press release: Rayca Precision and ASAKE partnership](https://www.biopharmadive.com/press-release/20260526-rayca-precision-and-asake-partner-on-ai-designed-therapeutics-for-rare-and-1/): AI-designed, physics-triaged therapeutics for rare and metabolic disease.